RxDoctor Payments Data

Nasreen Vohra, MD

Surgical Oncology · Greenville, NCNPI 1134308158

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,244 of the $1,293 with a category attached, or 96.2%. Histosonics, Inc. accounts for 96.2% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $1,244, more than ten times the $31 reported in 2019. That places this record below the midpoint for surgical oncology clinicians in NC, where the typical reported total is $1,293.

$1,293in general payments, 2019–2025

Across 4 payments — averaging $323.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Histosonics, Inc.$1K
  • Merck$18
  • AbbVie$17
  • Lexicon Pharmaceuticals, Inc.$14
$247,226in research payments, 2019–2025

Across 181 payments — averaging $1365.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$238K
  • Novartis$9K

What the payments were for

  • Travel & lodging$1,24496%
  • Food & beverage$494%

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Histosonics, Inc.1$1,244
Merck1$18
AbbVie1$17
Lexicon Pharmaceuticals, Inc.1$14

How this compares

$1,293 in reported general payments places this provider in the 50th percentile of 34 surgical oncology providers in North Carolina.

See all surgical oncology providers in North Carolina

Medicare billing

Part B allowed, 2024
$77,501
Medicare patients
153
Services billed
421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →